Baird Medical Investment Holdings Limited
BDMD
NASDAQ·Healthcare·Medical - Devices·Mkt cap $46.0M
$1.09
▼ -6.84%
P/E
-12.30
Mkt Cap
$46.0M
52-Wk Range
$0.76–$3.70
52-Week Range
$0.76 - $3.70
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 55.9% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Proprietary microwave ablation technology
- Established market presence in China's medical device sector
- Specialized expertise in minimally invasive tumor treatment
- Strong relationships with healthcare institutions and hospitals
Bear Case
1 risk
- Low volatility (beta -1.1).
Growth
Turning profitable
Rising cancer incidence and aging population in China
Value
Undervalued - trading well below Medical Devices peers
Momentum
Weak
-14.8% over 3m
Quality
Excellent
Solid business
Dividend
None
No dividend
Smart-money signal
Who's buying BDMD right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
SEP 3, 2026
Reported EPS of $0.04 vs $0.04 consensus (0.0% surprise). Revenue of $12.0M vs $12.0M expected (0.0%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
0.0%
Revenue trend · last 7Q
—
—
+14%
+20%
-39%
-39%
+25%
Q2 23
Q4 23
Q2 24
Q4 24
Q2 25
Q4 25
Q2 26
$1.7M
$2.9M
$1.9M
$3.5M
$1.2M
$2.2M
$9.9M
Margins · last 7Q
Gross
87.0%
Operating
8.5%
Profit
0.1%
Wall Street consensus
Analyst coverage
Live ratings and price targets aggregated across covering analysts.
vs Industry
How BDMD stacks vs Medical - Devices
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related